Cargando…

Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis

INTRODUCTION: Rapid identification of the causal organism and antibiotic resistance is crucial for guiding targeted therapy in patients with suspected staphylococcal infection. A meta-analysis was carried out to evaluate the diagnostic relevance of Xpert™ MRSA/SA (Xpert) from clinical samples of var...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojha, Suvash Chandra, Chen, Ke, Sun, Changfeng, Ahmed, Sarfraz, Sheng, Yun-Jian, Deng, Cun-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124268/
https://www.ncbi.nlm.nih.gov/pubmed/35451743
http://dx.doi.org/10.1007/s40121-022-00632-w
_version_ 1784711704866717696
author Ojha, Suvash Chandra
Chen, Ke
Sun, Changfeng
Ahmed, Sarfraz
Sheng, Yun-Jian
Deng, Cun-Liang
author_facet Ojha, Suvash Chandra
Chen, Ke
Sun, Changfeng
Ahmed, Sarfraz
Sheng, Yun-Jian
Deng, Cun-Liang
author_sort Ojha, Suvash Chandra
collection PubMed
description INTRODUCTION: Rapid identification of the causal organism and antibiotic resistance is crucial for guiding targeted therapy in patients with suspected staphylococcal infection. A meta-analysis was carried out to evaluate the diagnostic relevance of Xpert™ MRSA/SA (Xpert) from clinical samples of various origins for limiting the use of unnecessary empirical methicillin-resistant Staphylococcus aureus (MRSA) therapy. METHODS: Five databases, including the Cochrane Library, Scopus, PubMed, Web of Science, and Embase, were comprehensively inspected from inception to October 12, 2021. The pooled summary estimates were evaluated using a bivariate random-effects model. RESULTS: Our inclusion criteria were met by 49 publications containing 68 datasets out of 735 citations. A total of 21 studies (n = 4996) examined the accuracy of Xpert in detecting methicillin-sensitive S. aureus (MSSA), while 47 studies (n = 45,430) examined the accuracy of Xpert in detecting MRSA. As compared to MRSA, Xpert’s diagnostic performance for MSSA detection was markedly higher [sensitivity: 0.97 (0.96–0.98), specificity: 0.97 (0.97–0.98), area under curve (AUC): 0.99 (0.99–1.0)]. Xpert’s pooled sensitivity and specificity differed marginally across sample types, including screening of colonization, lower respiratory tract (LRT), osteoarticular, and bloodstream samples. Notably, the Xpert pooled specificity was consistently ≥ 92% against microbiological culture across all sample types. The diagnostic efficiency heterogeneity was not explained by a meta-regression and subgroup analysis of research design, sample conditions, and sampling methods (P > 0.05). CONCLUSION: Our findings suggest that Xpert could be used as the favoured screening test for the early detection of staphylococcal infection in a variety of sample types, with the goal of guiding therapeutic decisions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40121-022-00632-w.
format Online
Article
Text
id pubmed-9124268
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-91242682022-05-23 Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis Ojha, Suvash Chandra Chen, Ke Sun, Changfeng Ahmed, Sarfraz Sheng, Yun-Jian Deng, Cun-Liang Infect Dis Ther Original Research INTRODUCTION: Rapid identification of the causal organism and antibiotic resistance is crucial for guiding targeted therapy in patients with suspected staphylococcal infection. A meta-analysis was carried out to evaluate the diagnostic relevance of Xpert™ MRSA/SA (Xpert) from clinical samples of various origins for limiting the use of unnecessary empirical methicillin-resistant Staphylococcus aureus (MRSA) therapy. METHODS: Five databases, including the Cochrane Library, Scopus, PubMed, Web of Science, and Embase, were comprehensively inspected from inception to October 12, 2021. The pooled summary estimates were evaluated using a bivariate random-effects model. RESULTS: Our inclusion criteria were met by 49 publications containing 68 datasets out of 735 citations. A total of 21 studies (n = 4996) examined the accuracy of Xpert in detecting methicillin-sensitive S. aureus (MSSA), while 47 studies (n = 45,430) examined the accuracy of Xpert in detecting MRSA. As compared to MRSA, Xpert’s diagnostic performance for MSSA detection was markedly higher [sensitivity: 0.97 (0.96–0.98), specificity: 0.97 (0.97–0.98), area under curve (AUC): 0.99 (0.99–1.0)]. Xpert’s pooled sensitivity and specificity differed marginally across sample types, including screening of colonization, lower respiratory tract (LRT), osteoarticular, and bloodstream samples. Notably, the Xpert pooled specificity was consistently ≥ 92% against microbiological culture across all sample types. The diagnostic efficiency heterogeneity was not explained by a meta-regression and subgroup analysis of research design, sample conditions, and sampling methods (P > 0.05). CONCLUSION: Our findings suggest that Xpert could be used as the favoured screening test for the early detection of staphylococcal infection in a variety of sample types, with the goal of guiding therapeutic decisions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40121-022-00632-w. Springer Healthcare 2022-04-22 2022-06 /pmc/articles/PMC9124268/ /pubmed/35451743 http://dx.doi.org/10.1007/s40121-022-00632-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Ojha, Suvash Chandra
Chen, Ke
Sun, Changfeng
Ahmed, Sarfraz
Sheng, Yun-Jian
Deng, Cun-Liang
Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis
title Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis
title_full Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis
title_fullStr Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis
title_full_unstemmed Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis
title_short Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis
title_sort clinical relevance of xpert mrsa/sa in guiding therapeutic decisions for staphylococcal infections: a diagnostic test accuracy analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124268/
https://www.ncbi.nlm.nih.gov/pubmed/35451743
http://dx.doi.org/10.1007/s40121-022-00632-w
work_keys_str_mv AT ojhasuvashchandra clinicalrelevanceofxpertmrsasainguidingtherapeuticdecisionsforstaphylococcalinfectionsadiagnostictestaccuracyanalysis
AT chenke clinicalrelevanceofxpertmrsasainguidingtherapeuticdecisionsforstaphylococcalinfectionsadiagnostictestaccuracyanalysis
AT sunchangfeng clinicalrelevanceofxpertmrsasainguidingtherapeuticdecisionsforstaphylococcalinfectionsadiagnostictestaccuracyanalysis
AT ahmedsarfraz clinicalrelevanceofxpertmrsasainguidingtherapeuticdecisionsforstaphylococcalinfectionsadiagnostictestaccuracyanalysis
AT shengyunjian clinicalrelevanceofxpertmrsasainguidingtherapeuticdecisionsforstaphylococcalinfectionsadiagnostictestaccuracyanalysis
AT dengcunliang clinicalrelevanceofxpertmrsasainguidingtherapeuticdecisionsforstaphylococcalinfectionsadiagnostictestaccuracyanalysis